Public health perspective: from personalized medicine to personal health

Published on Mar 6, 2012in Personalized Medicine1.414
· DOI :10.2217/PME.12.16
Tomris Cesuroglu5
Estimated H-index: 5
(UM: Maastricht University),
Ben van Ommen41
Estimated H-index: 41
(TNO: Netherlands Organisation for Applied Scientific Research)
+ 3 AuthorsAngela Brand17
Estimated H-index: 17
(Manipal University)
A gradual shift from a ‘one-size-fits-all’ strategy towards personalized interventions is observed in the whole spectrum of healthcare, including personalized prevention, diagnosis and therapy, and the concept of personal health. This shift is caused by two major drivers. The first one is a general societal trend towards ‘personalization’, where individuals demand services or products that are customized to their needs, possibilities and choices. The second driver is rapid scientific and technological advancements in genomebased science and technologies (which is a term that covers the full breadth of knowledge that is being amassed in all ’omics fields [1,2]), information, and information and communication technologies (ICT). The future paradigm in health and healthcare has become increasingly visible in the past 10–15 years and has been commonly defined as ‘personalized medicine’ although the exact definition varies among different stakeholders and opinion leaders. In the ongoing communications, the term personalized medicine comprises two separate and independent approaches. The first approach is based on biomarkers and statistical methods subdividing a heterogeneous group into smaller less heterogeneous groups leading to stratified medicine. The strat ification into smaller and smaller subgroups is limited by the statistical power, and may therefore, not incrementally lead to individualization. The other approach is based on ’omics and other data obtained from the individual in conjunction with computer modeling approaches leading to ‘individualized medicine’. ‘Personalized’ mostly refers to the use of genome-based information and technologies for providing more stratified (and possibly personalized) interventions. Some authors put the emphasis not only on medicine but on healthcare
  • References (19)
  • Citations (15)
📖 Papers frequently viewed together
10 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1André F.S. AmaralH-Index: 19
#2Miquel Porta (Autonomous University of Barcelona)H-Index: 49
Last. Núria MalatsH-Index: 62
view all 14 authors...
Background and Aims Knowledge on the aetiology of exocrine pancreatic cancer (EPC) is scant. The best established risk factor for EPC is tobacco smoking. Among other carcinogens, tobacco contains cadmium, a metal previously associated with an increased risk of EPC. This study evaluated the association between concentrations of trace elements in toenails and EPC risk. Methods The study included 118 EPC cases and 399 hospital controls from eastern Spain. Levels of 12 trace elements were determined...
50 CitationsSource
#1Leigh Ann Simmons (Duke University)H-Index: 20
#2Michaela A. Dinan (Durham University)H-Index: 26
Last. Ralph SnydermanH-Index: 77
view all 4 authors...
Over the last decade, scientific discovery and technological advances have created great anticipation for capabilities to tailor individual medical decisions and provide personalized healthcare. Despite some advances, adoption has been sporadic and there remains a lack of consensus about what personalized healthcare actually means. This confusion has often resulted from the mistake of equating personalized medicine with genomic medicine, and thereby, attributing it as yet unfulfilled expectation...
34 CitationsSource
The Seventh Annual Harvard Personalized Medicine Conference was held at The Joseph B Martin Conference Center at the Harvard Medical School in Boston, MA, USA on the 9–10 November 2011. The 2-day conference program was designed to highlight the impact that personalized medicine is currently making clinically as it enters the healthcare delivery system. Going forward, policies, plans and actions of stakeholders including those from government, academia and the private sector need to be informed a...
2 CitationsSource
#1Jean BousquetH-Index: 124
#1Jean BousquetH-Index: 7
Last. Charles AuffrayH-Index: 51
view all 64 authors...
We propose an innovative, integrated, cost-effective health system to combat major non-communicable diseases (NCDs), including cardiovascular, chronic respiratory, metabolic, rheumatologic and neurologic disorders and cancers, which together are the predominant health problem of the 21st century. This proposed holistic strategy involves comprehensive patient-centered integrated care and multi-scale, multi-modal and multi-level systems approaches to tackle NCDs as a common group of diseases. Rath...
164 CitationsSource
#1Angela Brand (UM: Maastricht University)H-Index: 17
#2Helmut R. Brand (Manipal University)H-Index: 31
18 CitationsSource
#1Leroy HoodH-Index: 105
#1Leroy HoodH-Index: 103
Last. Stephen H. Friend (Sage Bionetworks)H-Index: 63
view all 2 authors...
The authors takes a systems-biology approach to the problems of personalized cancer medicine. They describe the challenges of moving to a discipline that is predictive, personalized, preventive and participatory and explore methods for overcoming these obstacles.
380 CitationsSource
#1Eric D. Green (NIH: National Institutes of Health)H-Index: 81
#1Eric D. Green (NIH: National Institutes of Health)H-Index: 8
Last. Mark S. Guyer (NIH: National Institutes of Health)H-Index: 38
view all 2 authors...
There has been much progress in genomics in the ten years since a draft sequence of the human genome was published. Opportunities for understanding health and disease are now unprecedented, as advances in genomics are harnessed to obtain robust foundational knowledge about the structure and function of the human genome and about the genetic contributions to human health and disease. Here we articulate a 2011 vision for the future of genomics research and describe the path towards an era of genom...
656 CitationsSource
At the European Health Forum Gastein in October 2010, personalized medicine was presented as a new paradigm for health care in Europe. I had the opportunity to participate in this session and to listen to the views of my esteemed co-participants on what can be done at the European level to achieve implementation of personalized medicine approaches and other emerging technologies. Personalized medicine is becoming an ever more important area for the application of genome-based information and tec...
8 CitationsSource
#1Andrea H. Brand (UM: Maastricht University)H-Index: 48
#1Angela Brand (UM: Maastricht University)H-Index: 17
High five?—5 years ago, we wrote the first Editorial1 and Viewpoint2 on Public Health Genomics for the European Journal of Public Health . We concluded that ‘public health in the future will be quite different from public health in the past’. Today, 5 years later, have we been right? Where are we now? The highly technology and bioinformatics-driven dynamics of genomics as a ‘moving target’ from the Human Genome Project (HGP) to the Personal Genome Project (PGP) is currently ‘shaking’ public heal...
16 CitationsSource
#1Kristine Sørensen (UM: Maastricht University)H-Index: 16
#2Helmut R. Brand (UM: Maastricht University)H-Index: 31
The complexity and novelty of public health genomics poses a challenge to ensure effective and responsible translation of genome-based information for the benefit of population health. The aim of this article is to provide literature-based insight into how the concept of health literacy can act as a catalyst for the translation process and to comment on the necessity to adapt new perspectives in a rapidly changing world, such as e.g. the health literacy-friendly approach of Google. Taking advant...
19 CitationsSource
Cited By15
#1Caitlyn Clabaugh (SC: University of Southern California)H-Index: 5
#2Kartik Mahajan (SC: University of Southern California)H-Index: 2
Last. Maja J. Matarić (SC: University of Southern California)H-Index: 76
view all 10 authors...
Socially assistive robots (SAR) have shown great potential to augment the social and educational development of children with autism spectrum disorders (ASD). As SAR continues to substantiate itself as an effective enhancement to human intervention, researchers have sought to study its longitudinal impacts in real-world environments, including the home. Computational personalization stands out as a central computational challenge as it is necessary to enable SAR systems to adapt to each child's ...
2 CitationsSource
#1Denis HorganH-Index: 6
#2Jonathan A. Lal (H.I., S.I.: University of Agriculture, Faisalabad)H-Index: 6
Personalised medicine promises to revolutionise healthcare, with its key goal of providing the right treatment to the right patient at the right time, and thus the potential of improving quality of life and helping to bring down healthcare costs. However, a major problem with broader implementation of personalised medicine is patient access to new drugs, devices and treatments. The fact that a new medicine or innovative product can sometimes take as long as 20 years to get from bench to bedside ...
1 CitationsSource
#1Tamar Sharon (UM: Maastricht University)H-Index: 6
Self-tracking devices point to a future in which individuals will be more involved in the management of their health and will generate data that will benefit clinical decision making and research. They have thus attracted enthusiasm from medical and public health professionals as key players in the move toward participatory and personalized healthcare. Critics, however, have begun to articulate a number of broader societal and ethical concerns regarding self-tracking, foregrounding their discipl...
87 CitationsSource
#1Barbara Prainsack ('KCL': King's College London)H-Index: 26
#2Alena Buyx (CAU: University of Kiel)H-Index: 15
38 Citations
Consumer-oriented mobile technologies offer new ways of capturing multidimensional health data, and are increasingly seen as facilitators of medical research. This has opened the way for large consumer tech companies, like Apple, Google, Amazon and Facebook, to enter the space of health research, offering new methods for collecting, storing and analyzing health data. While these developments are often portrayed as ‘disrupting’ research in beneficial ways, they also raise many ethical issues. The...
27 CitationsSource
#1Matthew Wai Heng Chung (Li Ka Shing Faculty of Medicine, University of Hong Kong)H-Index: 1
#2Joseph Chi Fung Ng (Li Ka Shing Faculty of Medicine, University of Hong Kong)H-Index: 1
People for and against direct-to-consumer (DTC) genomic tests are arguing around two issues: first, on whether an autonomy-based account can justify the tests; second, on whether the tests bring any personal utility. Bunnik et al , in an article published in this journal, were doubtful on the latter, especially in clinically irrelevant and uninterpretable sequences, and how far this claim could go in the justification. Here we argue that personal utility is inherent to DTC genomic tests and thei...
9 CitationsSource
#1Tomris Cesuroglu (UM: Maastricht University)H-Index: 5
#2Elena V. Syurina (UM: Maastricht University)H-Index: 6
Last. Anja Krumeich (UM: Maastricht University)H-Index: 13
view all 4 authors...
Objectives Various terms and definitions are used to describe personalised approaches to medicine and healthcare, but in ambiguous and inconsistent ways. They mostly have been defined in a top-down manner. However, actual practices might take different paths. Here, we aimed to provide a ‘practice-based’ perspective on the debate by analysing the content of ‘personalised’ practices published in the literature. Methods The search in PubMed and EMBASE (April 2014) using the terms frequently used fo...
9 CitationsSource
#1Vladimir Mićović (University of Rijeka)H-Index: 12
#2Iva Sorta-Bilajac Turina (University of Rijeka)H-Index: 2
Last. Đulija Malatestinić (University of Rijeka)H-Index: 2
view all 3 authors...
The relationship between personalised medicine and public health can be observed from three different standpoints, offering a framework for deliberation on the individual vs. social, i.e. personal/private vs. public, as follows: personalised medicine in public health, personalised medicine vs. public health and personalised medicine and public health. Analysis brings us to the third concept as the most suitable framework for the place and role of personalised medicine within the entire health ca...
1 CitationsSource
#1Sushravya Raghunath (Mayo Clinic)H-Index: 7
#2Srinivasan Rajagopalan (Mayo Clinic)H-Index: 16
Last. Richard A. RobbH-Index: 48
view all 9 authors...
Diffuse parenchymal lung diseases (DPLDs) are characterized by widespread pathological changes within the pulmonary tissue that impair the elasticity and gas exchange properties of the lungs. Clinical-radiological diagnosis of these diseases remains challenging and their clinical course is characterized by variable disease progression. These challenges have hindered the introduction of robust objective biomarkers for patient-specific prediction based on specific phenotypes in clinical practice f...
11 CitationsSource
#1Jonathan A. LalH-Index: 6
#2Anil Vaidya (UM: Maastricht University)H-Index: 4
Last. Angela BrandH-Index: 17
view all 5 authors...
We see a backlog in the effective and efficient integration of personalized medicine applications such as genome-based information and technologies into healthcare systems. This article aims to expand on the steps of a published innovative model, which addresses the bottleneck of real-time integration into healthcare. We present a deconstruction of the Learning-Adapting-Leveling model to simplify the steps. We found out that throughout the technology transfer pipeline, contacts, assessments and ...
6 CitationsSource